Magnevist Post-marketing Surveillance in Japan
NCT01376739
·
clinicaltrials.gov ↗
COMPLETED
Status
2051
Enrollment
INDUSTRY
Sponsor class
Conditions
Diagnostic Imaging
Interventions
DRUG:
Gadopentetate dimeglumine (Magnevist, BAY86-4882)
Sponsor
Bayer